Reference
- O'Brien, S.G., Guilhot, F., Larson, R.A., Gathmann, I., Baccarani, M., Cervantes, F., et al. (2003) "Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia", New England Journal of Medicine, 348, 994 — 1004.
- Investigators Brochure, STI571 (formerly CGP 57148B), and data on file, Novartis Pharma AG, Basel, Switzerland.